患有左心室辅助器件和前脉冲支持器件的患者中大动脉缺陷进展
Maks Mihalj1, Duc T Nguyen2, Ismael A Salas de Armas1
1Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.
概括
之前使用Impella增加了左心室辅助装置 (LVAD) 植入后渐进性大动脉衰竭 (AI) 的风险. 需要进一步的研究,以探索早期的大动脉置换是否可以改善结果.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 临床研究 临床研究
背景情况:
- 像Impella这样的穿皮临时左心室辅助装置 (LVAD) 已经改变了心脏性休克管理.
- 然而,在使用Impella后,大动脉衰竭 (AI) 的发生率和风险因素仍然不完全理解.
研究的目的:
- 评估在接受Impella支持的患者中逐渐AI的风险,Impella与随后的持久LVAD (Impella+LVAD) 以及没有先前的Impella支持的持久LVAD.
- 在这些患者群体中确定与渐进性AI相关的风险因素.
主要方法:
- 一个单一中心的回顾性队列研究分析了2019年1月1日至2023年8月31日的数据.
- 使用了两种框架:Impella框架 (将Impella+LVAD与Impella-Only进行比较) 和LVAD框架 (将Impella+LVAD与LVAD-Only进行比较).
- 渐进性AI (中度或严重) 是主要终点,通过心声回声图进行评估,并通过多变量建模进行风险因素分析.
主要成果:
- 在LVAD植入之前获得Impella支持的患者在12个月和24个月后呈现出明显更高的渐进性AI发病率,与没有先前获得Impella支持的患者相比.
- 在Impella框架中,渐进AI的调整后危险比率 (aHR) 为3.27 (p=0.002).
- 在LVAD框架中,渐进AI的aHR为7.87 (p<0.001).
结论:
- 之前的Impella支持与LVAD植入后逐渐AI的风险增加有关.
- 这表明,在LVAD植入期间,可能需要调查一下主动脉置换 (AVR) 的较低门.
- 需要进一步的前性研究来证实这些发现,并探索最佳管理策略.
更多相关视频
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
2.4K
05:18Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
89
相关概念视频
01:15Aortic Regurgitation I: Introduction
845
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
845
01:29Cardiomyopathy V: Interprofessional Care
520
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
01:22Mitral Stenosis I: Introduction
906
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
906
01:25Aortic Regurgitation III: Medical Management
499
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
499
01:17Aortic Regurgitation IV: Nursing Management
356
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
356
01:20Mitral Regurgitation I: Introduction
697
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
697